INFANTILE FIBROSARCOMA
Clinical trials for INFANTILE FIBROSARCOMA explained in plain language.
Never miss a new study
Get alerted when new INFANTILE FIBROSARCOMA trials appear
Sign up with your email to follow new studies for INFANTILE FIBROSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill tested in kids with Hard-to-Treat cancers
Disease control OngoingThis study is testing a pill called LOXO-292 in children and teenagers with advanced solid or brain tumors that have a specific genetic change called a RET alteration. The goal is to find a safe and effective dose and to see if the medicine can shrink these difficult-to-treat tum…
Matched conditions: INFANTILE FIBROSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Targeted drug trial offers hope for kids with rare, Hard-to-Treat cancers
Disease control OngoingThis study is testing a targeted drug called larotrectinib in children and young adults (up to age 30) with specific types of cancer. The cancers must have a rare genetic change called a TRK fusion. The goal is to see if the drug can shrink tumors or control leukemia before other…
Matched conditions: INFANTILE FIBROSARCOMA
Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC